WBMT Continental Regions 4 Continental regions used for the WBMT - - PowerPoint PPT Presentation

wbmt continental regions
SMART_READER_LITE
LIVE PREVIEW

WBMT Continental Regions 4 Continental regions used for the WBMT - - PowerPoint PPT Presentation

WBMT Continental Regions 4 Continental regions used for the WBMT Global Analysis AMR/PAH: Region of the Americas EUR: European Region EMR/AFR: Eastern Mediterranean/African Region SEAR/WPR: South-East Asia/Western Pacific


slide-1
SLIDE 1

WBMT Continental Regions

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

4 Continental regions used for the WBMT Global Analysis

  • AMR/PAH: Region of the Americas
  • EUR: European Region
  • EMR/AFR: Eastern Mediterranean/African Region
  • SEAR/WPR: South-East Asia/Western Pacific Region
slide-2
SLIDE 2

Origin of Global Data: Countries and participating institutions

  • 1 662 reporting transplant teams in 2016
  • 1 739 of 89 ‘known to be active’ countries currently reporting since 2006
  • AMR/PAH
  • United States: CIBMTR Canada: CBMTG
  • Argentina, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, Paraguay, Peru, Uruguay,

Venezuela: NATIONAL - LABMT

  • Brazil: SBMTO
  • EUR
  • 42 European countries: EBMT
  • EMR/AFR
  • Algeria, Egypt, Iran, Iraq, Jordan, Lebanon, Morocco, Oman, Pakistan, Qatar, Saudi Arabia, Tunisia:
  • EMBMT. Nigeria, South Africa: AFBMT
  • SEAR/WPR
  • Bangladesh, China, Hong Kong, India, Japan, Malaysia, Mongolia, Myanmar, Nepal, Philippines,

Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam: APBMT. Australia, New Zealand: ABMTRR

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

slide-3
SLIDE 3

WBMT: maximum number of reporting teams per country: 1 739

26 1 198 39 4 21 6 2 3 3 7 2 13

The Americas Eastern Mediterranean/Africa Europe South East Asia/Western Pacific

2 7 3 3 2 2 1 2 88 381 45 2 18 42 3 67 11 6 3 1 6 54 7 75 14 8 73 6 4 6 112 100 20 16 10 13 18 2 5 2 9 2 62 6 5 1 4 2 13 9 2 3 2 1 3 1 1 13 5 3 1 5 5 1 1 1 1 3 3 1 1 1 1 1 1

Not for publication

slide-4
SLIDE 4

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

200 400 600 800 1000 1200 1400 1600 1800 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

Reporting teams

10 20 30 40 50 60 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

N TX per team

WBMT global survey: 2006-2016

Not for publication

slide-5
SLIDE 5

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Main indications in 2016 Allogeneic HSCT

AML, 37,3% ALL, 17,9% CML, 2,9% MDS/MPS, 14,6% CLL, 1,2% Other leuk., 0,8% PCD, 1,7% HD/NHL, 8,6% ST, 0,2% BMF, 7,0% HG, 3,3% PID, 2,5% IDM, 0,8% AID, 0,1% Other NMD, 0,5% Others, 0,6%

Not for publication

slide-6
SLIDE 6

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Main indications in 2016 Autologous HSCT

AML, 1,48% ALL, 0,35% MDS/MPN, 0,0% CML+CLL, 0,05% PCD, 53,5% NHL, 28,2% HD, 8,4% ST, 6,44% NMD, 0,1% AID, 1,4% Others, 0,1%

Not for publication

slide-7
SLIDE 7

WBMT global survey: Trend 2006-2016 Allogeneic vs autologous HSCT

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

10000 20000 30000 40000 50000 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 H S C T Year Autologous Allogeneic

Not for publication

slide-8
SLIDE 8

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Trend 2006-2016 Donor type

8000 10000 12000 14000 16000 18000 20000 22000 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 H S C T Year Unrelated Family

Not for publication

slide-9
SLIDE 9

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Trend 2006-2016 Donor choice

5000 10000 15000 20000 07 08 09 10 11 12 13 14 15 16 H S C T Haplo incl. CB Unrelated incl CB Sibling/twin

Not for publication

slide-10
SLIDE 10

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Trend 2006-2016 Total HSCT by region

5000 10000 15000 20000 25000 30000 35000 40000 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 H S C T EUR AMR/PAH SEAR/WPR EMR/AFR

Not for publication

slide-11
SLIDE 11

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Trend 2006-2016 Allogeneic HSCT by region

2000 4000 6000 8000 10000 12000 14000 16000 18000 2006 2008 2010 2012 2014 2016 H S C T EUR SEAR/WPR AMR/PAH EMR/AFR

Not for publication

slide-12
SLIDE 12

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

WBMT global survey: Trend 2006-2016 Autologous HSCT by region

5000 10000 15000 20000 25000 2006 2008 2010 2012 2014 2016 H S C T EUR AMR/PAH SEAR/WPR EMR/AFR

Not for publication

slide-13
SLIDE 13

WBMT global survey: predicted activity 2020

Worldwide Network for Blood and Marrow Transplantation

NGO in official relations with World Health Organization

300000 600000 900000 1200000 1500000 1957 1959 1961 1963 1965 1969 1971 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019

Allo HSCT Auto HSCT Total HSCT

Not for publication